Skip to main content
. 2018 Jan 23;12:801. doi: 10.3332/ecancer.2018.801

Table 2. Important biochemical and immunological investigations of the patient with their reference ranges.

Biochemical
investigations
Patient’s result Reference range
Ca 9.3 8.8–10.1 mg/dl
Na 140 138–145 mmol/L
K 3.9 3.6–4.8 mmol/L
Cl 102 101–108 mmol/L
BUN 9 8–20 mg/dL
Creatinine 0.6 0.4–0.7 mg/dL
Uric acid 3.5 2.6–5.5 mg/dL
Total protein 7.7 6.6–8.1 g/dL
Albumin 4.8 4.1–5.1 g/dL
Total bilirubin 0.5 0.4–1.5 mg/dL
AST 11 13–30 U/L
ALT 9 7–23 U/L
LDH 172 124–222 U/L
CK 49 41–153 U/L
Glucose 107 73–109 mg/dL
eGFR 82 70–110
CRP 0.04 0–0.1 mg/dL
ANA -ve <10 IU/mL
RF 4.7 <15 IU/mL
EBV -ve -ve
HTLV >45 (High) <1 Cutoff Index (COI)
s IL-2R 3420 (High) <800 U/mL in HTLV-1 Asymptomatic carriers

ALT: Alanine transferase, ANA: antinuclear antibody, AST: aspartate transferase, BUN: blood urea nitrogen, CK: creatine kinase, EBV: epstein barr virus antibody, HTLV: human T-lymphotropic virus-1 monoclonal bands, RF: rheumatoid factor, eGFR: estimated glomerular filtration rate, sIL-2R: soluble interleukin-2 receptors